AARD

Aardvark Therapeutics (AARD)

About Aardvark Therapeutics (AARD)

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Details

Daily high
$4.44
Daily low
$4.06
Price at open
$4.06
52 Week High
$17.94
52 Week Low
$3.35
Market cap
89.0M
Dividend yield
0.00%
Volume
74,891
Avg. volume
138,403
P/E ratio
-1.27

Aardvark Therapeutics News

Details

Daily high
$4.44
Daily low
$4.06
Price at open
$4.06
52 Week High
$17.94
52 Week Low
$3.35
Market cap
89.0M
Dividend yield
0.00%
Volume
74,891
Avg. volume
138,403
P/E ratio
-1.27